A dark grid of evaluation tiles with green and blue highlights, representing scientist-reviewed life sciences AI training and evaluation data.

Life Sciences · · 8 min read

What to ask a scientific expert data vendor

Acumen Editorial · Updated November 20, 2026

Frontier labs are now doing drug development work, not just talking about it. On October 27, 2026, Anthropic reported early results from partner programs spanning target assessment, antibody design, lead optimization, manufacturing paperwork and trial planning. In one program, Claude reviewed 1,061 pages of manufacturing documentation, caught all 11 issues human reviewers had found and flagged seven more. Anthropic was also direct about where things stand: "All of this research is still at an early stage."

That is the context for every life sciences AI team buying expert data this year. Models are good enough to be useful in the lab and uneven enough to need scientists checking them. Training and evaluation data built by the right scientists is what closes that gap. Data built by the wrong ones widens it quietly.

The expert data market has moved from cheap generic labeling to expensive expert review (Sacra), and labs work with several providers at once (TechCrunch). So the question is not whether to buy. It's how to tell a vendor that can staff a protein engineering project from one that can staff a quiz. Here is what we would ask.

Why does scientific AI need a different kind of expert data?

Because the failure modes are different. Benchling's BenchBench-Protocol, published in August 2026, tests whether models can troubleshoot wet-lab protocols the way experienced scientists do. The best model scored 59.2%. Benchling's team put the gap simply: "knowing biology and doing biology are different things."

Their diagnosis matters for buyers. Models gave answers that sounded right but ignored instrument calibration, treated a visibly impure sample as pure, or missed small changes in technique. Benchling attributes this to training data that emphasizes clean published results over messy real outcomes.

OpenAI's LifeSciBench points the same way. Its 750 tasks were written by 173 PhD scientists with 19,020 rubric criteria. Tasks that required working with real artifacts like data files and images had a 28.1% pass rate, against 45.1% for text-only tasks. General knowledge is not the bottleneck. Hands-on judgment is.

Who exactly are the experts?

"PhD scientists" is a category, not a qualification. A structural biologist cannot grade a flow cytometry gating strategy. A medicinal chemist is the wrong reviewer for a bioprocess deviation.

Ask the vendor to name the disciplines, techniques and instruments its experts work with, and how recently. Ask whether credentials and current or recent bench experience are verified, and by whom. Ask how a task gets matched to an expert: by degree field, or by the specific method the task involves. The second answer is the one you want.

Does the data come from real lab work or from papers?

This is the question that separates vendors fastest. Rewriting a published methods section into a prompt produces data a model has largely seen already. It teaches the clean version of science.

The valuable material is what papers leave out. Benchling's experts studied thousands of real experiments and captured the adjustments scientists made to get published protocols working: swapped reagents, changed instruments, tuned incubation times. Scale Labs and Phylo's DrugDiscoveryBench found that expert hints let models solve most of the tasks they had failed on their own.

Ask the vendor whether experts write tasks from their own lab experience, including failed runs and troubleshooting. Ask whether tasks include raw artifacts such as plate reader exports, chromatograms, gel images or instrument logs, not only text.

How is each item reviewed, and how are disagreements settled?

Single-reviewer data hides errors. Benchling had multiple experts review each protocol adjustment before it became a task. That is the floor for scientific data, not a premium feature.

Ask how many independent experts review each item, whether they review blind to each other, and what happens when they disagree. A credible vendor has a written adjudication rule, a senior reviewer who breaks ties and a record of the disagreement rate per project. Disagreement is useful data. A vendor that reports none is not looking.

Can the reviewers catch a bad metric?

Expert review should cover the evaluation itself, not only the answers. In Anthropic's lead optimization program, the partner team found that its own standard heat-stability and clumping metrics may have been misleading, and the results had to be reanalyzed.

That is a scientist questioning the yardstick. Your vendor's experts should do the same: flag rubric items that reward the wrong behavior, reference answers that are out of date and tasks with more than one defensible answer. Ask for an example of a rubric or task the vendor's reviewers changed, and why.

Will the documentation hold up in a regulatory review?

In January 2026, FDA and EMA issued ten joint principles for good AI practice in drug development. They include multidisciplinary expertise, data governance and documentation, risk-based performance assessment and life cycle management. Training and evaluation data now sits inside that evidence chain.

Ask for a sample of the documentation that ships with each dataset: expert qualifications, task provenance, review history, versioning and change logs. If your quality team would not accept it, your regulatory team will not either.

Horizontal marketplace, vertical provider or in-house scientists?

Horizontal expert marketplaceVertical scientific data providerIn-house scientists
Expert poolEvery domain, large and broadLife sciences only, matched by discipline and techniqueYour own team's specialties
Best forVolume across many fields at onceSpecialized lab, discovery and CMC tasksProprietary programs and assays
Lab realismVaries by projectBuilt from bench experience and raw artifactsHigh, limited to your methods
Review depthVaries by projectMulti-expert review with written adjudicationDepends on spare scientist time
DocumentationGeneral-purposeBuilt for GxP and regulatory reviewInternal standards
Main trade-offDepth per disciplineNarrower scopeCost of pulling scientists off programs

Checklist: what to ask a scientific expert data vendor

  • Which disciplines, techniques and instruments do your experts cover?
  • How are credentials and recent bench experience verified?
  • How is each task matched to an expert: by degree or by method?
  • Are tasks written from real lab work, including failed experiments?
  • Do tasks include raw artifacts, not only text?
  • How many independent experts review each item?
  • Do reviewers work blind to each other?
  • What is your written adjudication rule, and who breaks ties?
  • What disagreement rate did your last comparable project show?
  • Can you show a rubric or metric your reviewers corrected?
  • What documentation ships with each dataset?
  • How are datasets versioned as methods and guidance change?

How Acumen helps

We work only in healthcare, life sciences and pharma. Acumen matches verified scientists to each task by discipline and technique, builds tasks from real bench experience and raw lab artifacts, and runs multi-expert review with documented adjudication. Every dataset ships with the provenance and review records your quality and regulatory teams expect.

See scientific expert data for life sciences AI. If you are testing models rather than training them, see life sciences model evaluation. For what the newest wet-lab benchmark shows, read what BioBasicsBench means for life sciences AI teams.

Request a sample dataset Schedule a conversation

FAQ

What should I ask a scientific expert data vendor first?

Ask which disciplines, techniques and instruments its experts actually work with, and how tasks are matched to them. A PhD in one field is not a qualified reviewer in another. The right vendor matches by method, verifies recent bench experience and can show you the expert profile behind each task before the project starts.

Why do AI models struggle with real lab work?

Benchling's BenchBench-Protocol found models gave plausible answers that missed how experiments behave, such as ignoring instrument calibration or treating an impure sample as pure. The best model scored 59.2%. Benchling attributes the gap to training data that favors clean published results over the messy outcomes scientists deal with at the bench.

What makes scientific training data better than data built from papers?

Papers report the version of an experiment that worked. Useful training data captures what they leave out: reagent swaps, instrument changes, failed runs and troubleshooting. Benchling built its benchmark from thousands of real experiments for this reason, and DrugDiscoveryBench found that expert hints let models solve most tasks they had failed alone.

How many experts should review each scientific data item?

At least two independent experts, reviewing blind, with a written rule for settling disagreements and a senior reviewer to break ties. Benchling had multiple experts review each protocol adjustment before it became a benchmark task. Ask vendors to report the disagreement rate on comparable projects, since a rate of zero usually means nobody was checking.

Do FDA and EMA rules apply to AI training data in drug development?

In January 2026, FDA and EMA published ten joint principles for good AI practice in drug development, including multidisciplinary expertise, data governance and documentation, and life cycle management. They are principles, not detailed rules, but they make the provenance and review history of training and evaluation data part of the evidence regulators may ask about.

Should we use a horizontal expert marketplace or a vertical provider?

Horizontal marketplaces fit projects that need volume across many fields at once. A vertical provider fits specialized discovery, lab and CMC work where discipline matching, review depth and regulatory documentation matter more than breadth. Many teams use both. The checklist questions on expert match, lab realism and adjudication apply either way.

From the Acumen archive. Explore expert data and Healthcare & Pharma.

← Back to Insights